Issue #3: Genetic and Hereditary Cancers
Added April 7, 2006 | Written by Robert Smith, Linda Petock for the
Market Edition
This report is focused on the analysis of the market for genetic testing as it relates to hereditary cancers, namely breast, ovarian and colorectal cancers. An analysis performed by Dorland Healthcare Information estimates the United States market for this testing was $510 million in 2005, with forecasted growth to $665 million in 2010, representing a compound growth rate of 6% during the forecast period.
The complete report is available here for individual purchase or with a subscription. The complete report is 63 pages and addresses additional details to consider. Also included are the supplements on: the market forecast; companies active in genetic testing, service, competing and complementary technologies; adoption by selected medical centers.
The complete report is available here for individual purchase or with a subscription. The complete report is 63 pages and addresses additional details to consider. Also included are the supplements on: the market forecast; companies active in genetic testing, service, competing and complementary technologies; adoption by selected medical centers.